Fueger Barbara J, Czernin Johannes, Hildebrandt Isabel, Tran Chris, Halpern Benjamin S, Stout David, Phelps Michael E, Weber Wolfgang A
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
J Nucl Med. 2006 Jun;47(6):999-1006.
UNLABELLED: Small-animal PET scanning with (18)F-FDG is increasingly used in murine models of human diseases. However, the impact of dietary conditions, mode of anesthesia, and ambient temperature on the biodistribution of (18)F-FDG in mice has not been systematically studied so far. The aim of this study was to determine how these factors affect assessment of tumor glucose use by (18)F-FDG PET and to develop an imaging protocol that optimizes visualization of tumor xenografts. METHODS: Groups of severe combined immunodeficient (SCID) mice were first imaged by microPET with free access to food, at room temperature (20 degrees C), and no anesthesia during the uptake period (reference condition). Subsequently, the impact of (a) fasting for 8-12 h, (b) warming the animals with a heating pad (30 degrees C), and (c) general anesthesia using isoflurane or ketamine/xylazine on the (18)F-FDG biodistribution was evaluated. Subcutaneously implanted human A431 epidermoid carcinoma and U251 glioblastoma cells served as tumor models. RESULTS: Depending on the study conditions, (18)F-FDG uptake by normal tissues varied 3-fold for skeletal muscle, 13-fold for brown adipose tissue, and 15-fold for myocardium. Warming and fasting significantly reduced the intense (18)F-FDG uptake by brown adipose tissue observed under the reference condition and markedly improved visualization of tumor xenografts. Although tumor (18)F-FDG uptake was not above background activity under the reference condition, tumors demonstrated marked focal (18)F-FDG uptake in warmed and fasted animals. Quantitatively, tumor (18)F-FDG uptake increased 4-fold and tumor-to-organ ratios were increased up to 17-fold. Ketamine/xylazine anesthesia caused marked hyperglycemia and was not further evaluated. Isoflurane anesthesia only mildly increased blood glucose levels and had no significant effect on tumor (18)F-FDG uptake. Isoflurane markedly reduced (18)F-FDG uptake by brown adipose tissue and skeletal muscle but increased the activity concentration in liver, myocardium, and kidney. CONCLUSION: Animal handling has a dramatic effect on (18)F-FDG biodistribution and significantly influences the results of microPET studies in tumor-bearing mice. To improve tumor visualization mice should be fasted and warmed before (18)F-FDG injection and during the uptake period. Isoflurane appears well suited for anesthesia of tumor-bearing mice, whereas ketamine/xylazine should be used with caution, as it may induce marked hyperglycemia.
未标注:使用(18)F-FDG的小动物PET扫描在人类疾病的小鼠模型中应用越来越广泛。然而,饮食条件、麻醉方式和环境温度对(18)F-FDG在小鼠体内生物分布的影响,迄今为止尚未得到系统研究。本研究的目的是确定这些因素如何影响通过(18)F-FDG PET对肿瘤葡萄糖利用情况的评估,并制定一种优化肿瘤异种移植可视化的成像方案。 方法:将重度联合免疫缺陷(SCID)小鼠分组,首先在室温(20摄氏度)下自由进食且在摄取期不麻醉的情况下,通过微型PET进行成像(参考条件)。随后,评估以下因素对(18)F-FDG生物分布的影响:(a)禁食8 - 12小时;(b)用加热垫使动物升温(30摄氏度);(c)使用异氟烷或氯胺酮/赛拉嗪进行全身麻醉。皮下植入的人A431表皮样癌和U251胶质母细胞瘤细胞用作肿瘤模型。 结果:根据研究条件,正常组织对(18)F-FDG的摄取情况为:骨骼肌变化3倍,棕色脂肪组织变化13倍,心肌变化15倍。升温及禁食显著降低了在参考条件下观察到的棕色脂肪组织对(18)F-FDG的强烈摄取,并显著改善了肿瘤异种移植的可视化效果。尽管在参考条件下肿瘤对(18)F-FDG的摄取未高于背景活性,但在升温和禁食的动物中,肿瘤表现出明显的局灶性(18)F-FDG摄取。定量分析显示,肿瘤对(18)F-FDG的摄取增加了4倍,肿瘤与器官的比值增加高达17倍。氯胺酮/赛拉嗪麻醉导致明显的高血糖,未作进一步评估。异氟烷麻醉仅轻度升高血糖水平,对肿瘤(18)F-FDG摄取无显著影响。异氟烷显著降低了棕色脂肪组织和骨骼肌对(18)F-FDG的摄取,但增加了肝脏、心肌和肾脏中的活性浓度。 结论:动物处理对(18)F-FDG的生物分布有显著影响,并显著影响荷瘤小鼠微型PET研究的结果。为改善肿瘤可视化效果,应在注射(18)F-FDG前及摄取期对小鼠进行禁食和升温处理。异氟烷似乎非常适合用于荷瘤小鼠的麻醉,而氯胺酮/赛拉嗪应谨慎使用,因为它可能诱发明显的高血糖。
J Nucl Med. 2006-6
J Nucl Med Technol. 2006-3
Exp Biol Med (Maywood). 2025-6-19
Front Med (Lausanne). 2025-5-21
Int J Mol Sci. 2025-2-8
Front Nucl Med. 2024-4-11
Mol Imaging Biol. 2024-12
Cancers (Basel). 2024-7-19